-
16m 3sPart 2 | Session 1 The Coalition ACTION Trial: Dr Harriette Van Spall & Dr Renato Lopes
-
16m 20sPart 2 | Session 2 The RADIANCE-HTN TRIO Trial: Dr Harriette Van Spall & Dr Ajay J Kirtane
-
15m 2sPart 2 | Session 3 The ISCHEMIA Trial: Dr Harriette Van Spall & Dr Gregg Stone
-
11m 30sPart 2 | Session 4 The LIFE Trial: Dr Harriette Van Spall & Dr Douglas L Mann
-
9m 1sPart 2 | Session 5 The STRENGTH Study: Dr Harriette Van Spall & Dr Steven E Nissen
-
16m 6s
-
11m 22sPart 3 | Session 1 Findings from the WASE COVID Study: Dr Frederico M Asch
-
12m 33sPart 3 | Session 2 The Prague OCHA Study: Dr Jan Belohlavek
-
7m 15sPart 3 | Session 3 The VOYAGER PAD Trial: Dr Rupert Bauersachs
-
8m 58sPart 3 | Session 4 30-day Results of the TRISCEND Study: Dr Susheel Kodali
-
10m 38sPart 3 | Session 5 The HOLIDAY Monitors Trial: Dr Gregory Marcus
-
Part 3 | Session 6 The CONNECT-HF Trial: Dr Adam DeVore
-
15m 45sPart 3 | Session 7 The DARE-19 Randomized Trial: Dr Mikhail Kosiborod
-
10m 39sPart 3 | Session 8 The Tailor-PCI Follow-up Study: Dr Naveen Pereira
-
9m 28sPart 3 | Session 9 Findings From the RESCUE Trial: Dr Paul M Ridker
-
15m 1sPart 3 | Session 10 The SAFE-PAD Study: Dr Eric Secemsky
-
11m 45sPart 3 | Session 11 Findings From the HOST-EXAM Trial: Dr Hyo-Soo Kim
-
15m 16sPart 3 | Session 12 Findings from the RAFT-AF Trial: Dr Anthony Tang
Our regular review series View from the Thoraxcenter hosted by Prof Nicolas Van Mieghem and Dr Joost Daemen (Thoraxcentre, Erasmus MC, Rotterdam, NL) provided a concise analysis of the late-breaking science results.
For a deeper dive into key randomized clinical trial data, Dr Harriette Van Spall (McMaster University, Hamilton, CA) interviewed principal investigators on their studies, learnings, and applicability to clinical practice in her regular Late-Breaker Discussion Series.
Short, accessible Expert Interviews were conducted with select faculty focusing on the results, applicability, and impact on future research.
The ACC. 21 Edition of Masterclass video highlighted the results of the ACC Survey on the hostile work environment.
More from this programme
Part 1
View from the Thoraxcenter: Wrap Up
Part 2
Late-breaker Discussion Series
Part 3
Expert Interviews
Part 4
Masterclass
Faculty Biographies
Nicolas M Van Mieghem
Medical Director
Prof Nicolas Maria Van Mieghem is an Interventional cardiologist at Thoraxcenter, Erasmus MC, Rotterdam, NL decided to pursue a career that would help others. “I enjoy the feeling of being able to help someone or do something important for them". His father was a general cardiologist and one of his biggest influences early in his career.
Prof Van Mieghem initially intended to train as a cardiac surgeon but decided to specialise in interventional cardiology instead, following advice from a mentor. This decision was cemented when he read the first-in-human case report of transcatheter aortic valve implantation (TAVI) in Circulation by Alain Cribier in 2002. Prof Van Mieghem believes that great cardiologist genuinely cares for their patients. He names Gary Roubin, Dr Manu Malbrain and Professor Patrick Serruys among his mentors.
His current research focuses on cerebral embolic protection during TAVI and the search for improved…
Joost Daemen
Interventional Cardiologist
Dr Joost Daemen, MD, PhD is a senior interventional cardiologist at the Thorax Center, Erasmus MC, Rotterdam, NL. Dr Daemen obtained his degree in medicine at the Erasmus University Medical Center, Rotterdam in 2005 and did 2 years of internal medicine training and 4 years of general cardiology training at the Thoraxcenter, Rotterdam.
Dr Daemen is actively involved in several drug-eluting stent trials and is Principal Investigator of four trials focusing on the safety and efficacy of renal sympathetic denervation in hypertension, heart failure, vasospastic angina and heart failure. Dr Daemen is a member of the editorial board of EuroIntervention and the Netherlands Heart Journal, member of Young ICIN, and has completed courses in biomedical statistics and device training.